Eli Lilly (LLY +0.78%) and Novo Nordisk (NVO +0.02%) are competing in the market for weight loss and diabetes treatments.
*Stock prices used were the afternoon prices of Aug. 9, 2025. The video was published on Aug. 11, 2025.

Investors have a tough choice between these two excellent companies.
Eli Lilly (LLY +0.78%) and Novo Nordisk (NVO +0.02%) are competing in the market for weight loss and diabetes treatments.
*Stock prices used were the afternoon prices of Aug. 9, 2025. The video was published on Aug. 11, 2025.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.